Evangelos S. Gragoudas,Vasiliki Poulaki,Joan W. Miller
申请号：
US15155495
公开号：
US20170035883A1
申请日:
2016.05.16
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Provided are methods and compositions for treating ocular conditions characterized by the presence of unwanted choroidal neovasculature, for example neovascular age-related macular degeneration. The selectivity and sensitivity of, for example, a photodynamic therapy (PDT)based approach can be enhanced by combining the PDT with an anti-FasL factor, for example, an anti-FasL neutralizing antibody.
